The stock of Israel Chemicals Ltd. (NYSE:ICL) has been Initiated to Overweight by Stephens in its latest research note that was published on March 12. Citigroup analysts bumped their recommendation on ICL stock from Neutral to Buy in a separate flash note to investors on March 21
Israel’s stock is covered by 3 analysts, with 1 of them rating the stock as Buy. It has been deemed to have strong buy by 1 of the analysts, 1 of them have rated it as a Hold while none of them rated it as sell. The situation was different a month ago when the stock was rated as a Buy by only 1 analysts. none of them rated it as strong buy with 2 of them recommended investors to Hold on to the stock. Meanwhile, none analyst(s) rated it as a sell. The above data shows that ICL has an average analyst rating of 2.00.
Israel Chemicals Ltd., which has current market capitalization of above $7 Billion, published its last quarter earnings on June 30, 2019. The company was able to amass $1425 million in revenue. This figure is $55 million more than what analysts had expected which was $1480 million. During the first quarter of the year, Israel also recorded $0.12 earnings per share (EPS) which is $0.02 above the $0.1 estimated by Thomson Reuter’s analyst, leading to a surprise factor of 25%.
ICL declined by $-0.14 during the normal trading session on Tuesday and reaching a high of $5.24 during the day while it closed the day at $5.20. The Israel stock had a low trading volume of 0.16 million shares on that day, which is low compared to the average daily volume of 147.93M shares. ICL has also lost 3.70% of its value over the past 7 days. However, the stock has declined by 3.88% in the 3 months of the year. Over the past six months meanwhile, it has lost 5.45% while it has lost 8.13% year-on date. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -5.45% from its 3 months high price. However, taking another look at ICL will indicate that it is trading +5.69% away from its 90-day low. Looking at the bigger picture, the Israel Chemicals Ltd. stock has dropped by -24.64% from its 52-week high while it has surged by +5.69% from its 52-week low price.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 41.18%. This figure is better than the company’s 20-day Raw Stochastic average which currently stands at 34.78%. Over the past 20 days, Israel’s Stochastic %K stood at 64.08% while its Stochastic %D was revealed to be 75.73%.